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Abstract
In this work, the photophysical properties of the fluorescent anticoagulant
drug warfarin (W) were examined in water and inside methyl-β-cyclodextrins (Me-βCD) through absorption and time-resolved fluorescence measurements at pH 3 and 9
and upon the selective excitation of different isomers of warfarin at 280 and 320 nm.
The values of binding constants (2.9 × 103 M–1 and 4.2 × 102 M–1 for protonated and
deprotonated forms, respectively) were extracted from the spectrophotometric data.
Both absorption and time-resolved fluorescence results established that the interior of
the macromolecular host binds preferentially the open protonated form, red shifts the
maximum of its absorption of light at ~305 nm, extends its excited-state lifetime, and
decreases its emission quantum yield (ՓF). Collectively, sequestration of the open
guest molecules decreases markedly their radiative rate constants (kr), likely due to
formation of hydrogen-bonded complexes in both the ground and excited states. Due
to lack of interactions, no change was observed in the excited-state lifetime of the
cyclic form in the presence of Me-β-CD. The host also increases the excited-state
lifetime and ՓF of the drug deprotonated form (W-). These later findings could be
attributed to the increased rigidity inside the cavity of Me-β-CD. The pKa values
extracted from the variations of the UV-visible absorption spectra of W versus the
pH of aqueous solution showed that the open isomer is more acidic in both ground
and excited states. The positive shifts in pKa values induced by three derivatives of
cyclodextrins: HE-β-CD, Ac-β-CD, and Me-β-CD supported the preferential binding
of these hosts to open isomers over cyclic.
Keywords: open-cyclic tautomers, molecular switching, decay-associated spectra,
warfarin, excited-state lifetime, cyclodextrins.
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)Title and Abstract (in Arabic

تأثير تكوين معقدات داخل أوعية السيكلودكسترين على خاصية االنفتاح واالنغالق في
دواء الوارفارين
الملخص

في هذا العمل  ،تم فحص الخواص الفيزيائية الضوئية لعقار الوارفارين المضاد للتجلط
الدموي في الماء وداخل األوعية الجزيئية للميثيل-سيكلودكسترين ( )Me-β-CDمن خالل
قياسات االمتصاص واالنبعاث عند الرقم الهيدروجيني  3و  9الخاصة بايزومرات مختلفة من
الوارفارين .تم استخالص معامالت االرتباط ( 103 × 2.9متر

1-

و  102 × 4.2متر) 1-

ألشكال حمضية وقاعدية مختلفة للعقار .أثبتت كل من نتائج االمتصاص واالنبعاثات الحركية أن
الجزء الداخلي من المضيف يفضل االرتباط بالشكل الحمضي المفتوح  ،مسببا امتصاص العقار
لطاقة ضوئية أقل عند  ~ 305نانومتر  ،وإطالة العمرالزمني للحالة المثارة  ،كما يقلل من نسبة
االنبعاث ) .(ՓFوبشكل عام إن االرتباط بواسطة جزيئات الضيف بالشكل ذو خاصية االنفتاح
تقلل بشكل ملحوظ من معامالت اإلشعاع ( )krللدواء ،ويرجع ذلك إلى تكوين روابط
هيدروجينية في كل من الحالة المستقرة و المثارة.
مفاهيم البحث الرئيسية :التحول الجزيئي ،األطياف الحركية ،زمن الحالة المثارة ،أوعية
السيكلودكسترين ،وارفارين.
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Chapter 1: Introduction
1.1 Relevant Literature
1.1.1 Supramolecular Chemistry as a Science
Since its first development in 1987 by Lehn, Cram and Pedesen [1].
supramolecular chemistry has been expanding into various applications, including
biomedical applications [2], [3]. The host-guest concept involves non-covalent
interaction of a guest (G) molecule inside the cavity of a host (H) molecule (Figure
1). These interactions include hydrogen-bonding interaction, π−π stacking
interaction,

electrostatic

interaction,

van

der

Waals

force,

and

hydrophobic/hydrophilic attraction [4].

Figure 1: Self-assembly (a), self-sorting (b) and stimuli-responsiveness of
supramolecular systems (c)

Figure 1 illustrates two important features of those non-covalent interactions:
reversibility and responsiveness to external stimuli, such as pH, light, electrical
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signal, heat, chemical competitor, etc. While self-assembly process (Figure 1a)
describes transformation of small building blocks into one defined aggregate under
certain conditions, self-sorting (Figure 1b) process is simultaneous occurrence of
multiple self-assemblies into multiple well-defined aggregates under similar
conditions. If building blocks of those self-assembling or self-sorting systems reconfigured in responding to certain stimuli, the systems said to be stimuli-responsive
systems (Figure 1c).
Supramolecular materials are naturally composed of two or more components
that intrinsically self-assembled by non-covalent interactions. Such weak interactions
inherently endow the materials with reversible, spontaneous assembly or disassembly
feature, allowing convenient dissociation and reconstruction of the supramolecular
systems at a low energy cost. Consequently, the “bottom-up” supramolecular
approach has an adaptive capability in response to external stimuli that can trigger
the self-assembly/disassembly equilibrium at the molecular level, leading into the
design and fabrication of stimuli-responsive functional, smart materials for various
applications, such as in biomedicine [5].
When compared to routine covalent modifications, the non-covalent method
considered inexpensive and environmentally safe approach. On the one hand, it
bypasses the burdens in multiple organic synthesis steps [6], and on the other it may
combine already existing products in the market, whose safety and low-toxicity have
been already confirmed [7], [8]. The low toxicity, in particular, motivated more
researchers to utilize supramolecular systems in biological field as bio-inspired
materials [9], [10].

3
1.1.2 Types of Molecular Containers (Hosts)
There have been several host-guest systems reported in aqueous solution for
biomedical applications with stimuli-responsive abilities [11]. Cyclodextrins (CDs)
[12] and Cucurbit[n]uril (CBs) [13] are examples of hosts that bind with the guest by
noncovalent interactions as illustrated in Figure 2.

Ac-β-CD

HE-β-CD
Figure 2: Chemical structures of various derivatives of cyclodextrins (CDs) and
cucurbiturils (CBs) molecular containers
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Table 1 summarizes some features that distinguish the two type of containers
CDs and CBs. For example, CBs have much higher affinity to bind guest molecules
[2]. For instance, the binding constant (K) for CDs-based host−guest complexes can
reach 104 M−1 [12], [14], [15], and that for CBs-based host−guest complexes can be
as high as 1015 M−1 [16]. Another important feature is the distinct carbonyl group,
which is responsible for the binding between CBs and cationic guests through iondipole interactions, leading to an increase in their acid-dissociation constant [17].
However the important feature of CDs is their ability to increase the
solubility of poorly soluble drugs [12], [14], [15]. CDs consist of (α-1,4-)-linked αD-glucopyranose units with a hydrophobic central cavity which gives CDs the cones
shape with the hydrophilic outer surface [12], [14], [15]. There are three main types
of CDs (α, β and γ), the difference between them is the number of glucopyranose
units in their structures which is six, seven and eight, respectively [12], [14], [15].
On the other hand, CBs composed of glycoluril units connected by methylene
groups. The isolation of major CBs members was achieved only 80 years after its
first synthesis in acidic media. By the year 2000, all members of CBs from 1-10 were
isolated except CB9 (i.e., CB5, CB6, CB7, CB8, and CB10) [18]–[20]. In 2015,
CB14 was isolated [21].

5
Table 1: Major differences between CBs and CDs molecular containers

Binding constant

CBs

CDs

1015 M−1

104 M−1

Features

carbonyl group and
ion-dipole interactions
(increase pKa of guests)

increase the solubility of
insoluble guests

Structure

composed of glycoluril units
connected by methylene
groups with a hydrophobic
cavity

Composed of glucopyranose
units with a hydrophobic
cavity

Types

CB5, CB6, CB7, CB8, CB10,
and CB14

α, β and γ and derivatives
thereof

1.1.3 pKa of other drugs inside CBs and CDs
In general, inclusion of guest molecules inside CDs and CBs changes their
physical and chemical properties. Also, CDs prefer to bind the neutral forms of
guests over their cationic forms, consequently, this will induce negative pKa shift of
guest molecules[2], [22]–[24]. On the other hand, CBs will induce positive pKa shift
of guest molecules because it favors binding the protonated form rather than the
neutral form [25]–[27]. The host-induced pKa shift was related to the carbonyl
groups of CBs that are partially negatively charged [2], [25], [28]–[31].
For example, Saleh et al. studied the encapsulation of benzimidazoles [26],
[32] which are commercial fungicides [33], [34] with CB7. The inclusion affects the
pKa of the benzimidazoles and leads to positive pKa shift. This is equivalent to say
that, CB7 has stabilized the protonated form of benzimidazole guest molecule,
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increasing its solubility [26]. In another example, the interaction of CB7 with
tropicamide which is an ocular drug; whose pKa is 5.4 was also examined [35], [36].
Encapsulation of tropicamide with CB7 and CB8 increases the pKa by (0.5 and 1.5)
units respectively. As a result, the ionization degree of the drug was enhanced, which
is of relevant to drug bioavailability [35].
From a different prospective, inclusion of drugs inside CDs and CBs has not
only induced pKa shift but also increased the fluorescence of these drugs [31], [35].
Koner et al. studied the encapsulation of dapoxyl sodium sulfonate (DSS) with αand β-cyclodextrins. Not only a 0.8 negative pKa shift was noticed due to
encapsulation of DSS inside β-cyclodextrins, but also the emission of the DSS was
consequently increased significantly [37].
1.1.4 Biochemistry of Warfarin and its Importance
Warfarin is an oral anticoagulant drug that is widely used for a patient who has
cardiovascular disease [38]. The mechanism of how warfarin prevents blood from
clotting is shown in Figure 3 [39], which illustrates Vitamin K cycle. Warfarin
reduces the production of clotting factors II, VII, IX and X, and the anticoagulant
proteins C and S. This could happen by inhibiting the enzyme, Vitamin K epoxide
reductase, that is required to reproduce vitamin K epoxide in the reduced form.
Reduced vitamin K1 (vitamin K1H2) is required as cofactor for γ-carboxylase to
converts glutamic acid (Glu) residues to γ-carboxyglutamic acid (Gla) by adding
CO2, which is needed to induce blood clotting [39].
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Vitamin K1H2
-

Vitamin K1

DT-diaphorases
+NAD(P)H

The vitamin K
Cycle

-

CO + O2
Epoxidase

Warfarin

VKOR + e

γ-Carboxylase

CH

VKOR + e

Vitamin K1>O
Figure 3: Vitamin K cycle

1.1.5 Warfarin as Fluorescent Probe
The fluorescence properties of warfarin which is a coumarin derivative [40]
have attracted attention for several decades. Like other fluorescent probes, coumarins
display photophysical properties that are sensitive to their local environments, such
as supramolecular host cavities [41]. Within this context, supramolecular host-guest
approach alongside fluorescence behavior of new coumarin derivative was exploited
by Saleh et al. towards molecular recognition of optically inactive analytes [42].
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There have been number of studies on the structures of W in different
solvents and at different pH by NMR, absorption and time-resolved fluorescence
[43]–[46]. The early precedent reports described structures of drug in solution [43],
[44] to be present at pH lower than its pKa ~ 5 as either open or cyclic protonated
form and at pH higher than its pKa as deprotonated form, whose side chain is open.
In addition to that, photophysical properties of W in different solvents and solvent
mixtures were profoundly examined [45], [46].
1.1.6 Time-Resolved Fluorescence
One of the most powerful tools for investigating the physical and chemical
properties of matter or biological systems is the time-resolved fluorescence
spectroscopy [47]. This becomes essential in light of the fact that steady state
emission spectra sometimes are unspecified because the overlap emission profile of
different fluorophores. In addition, steady-state fluorescence spectroscopy is not
quantitative due to bleaching effects and gives no information in relation to the rate
of deactivation process of an exited state of a drug molecule, as summarized by the
Jablonski diagram in Figure 4 [48].
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Sn
Tn
Internal
conversion

Fluorescence

Absorption

S1
T1

S0
Figure 4: Representative Jablonski diagram

1.1.6.1 Time-Correlated Single Photon Counting (TCSPC)
One of the most popular ways of measuring time-resolved fluorescence is
(TCSPC). The principle of this method is illustrated in Figure 5 [48]. A molecule
will be excited by a laser pulse, a beam splitter is used to split part of the laser light
which will reach to the photodiode. The photodiode is responsible for forming an
electrical pulse that will be converted to ‘start’ signal by the discriminator. However,
the stop signal is produced from the photon emitted by the sample that is recorded by
a photomultiplier. The start signal is then required to start the time-to-amplitude
converter (TAC).
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TAC is the most important part of the TCSPC technique because of its role,
which is measuring the difference in time between the start and stop signals that are
proportional to the analogue voltage signal. Consequently, the voltage that produced
by TAC is stored in a multi-channel analyzer [48].

Figure 5: Time-correlated single photon counting (TCSPC) diagram
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1.2 Aim of This Study
Our goal is to characterize the photophysical behaviors of warfarin (W) inside
cyclodextrin macrocycles as shown in (Figure 6). In previous work, steady-state
fluorescence measurements were studied. However, to understand the effect of
encapsulation of warfarin on emission, a more quantitative tool for examining the
effects of supramolecular cavities is needed. Accordingly, measurements of
fluorescence lifetimes of W in presence and absence of cyclodextrins are highly
motivated in the present work.

Figure 6: Structural formulas of protonated warfarin (W): Keto-Enol tautomerism,
deprotonated warfarin (W−), and methyl-β-cyclodextrins (Me-β-CD) molecular
container
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Chapter 2: Experimental Work
2.1 Reagents
Wafarin (W), Acetyl-β-cyclodextrins (Ac-β-CD), Methyl-β-cyclodextrins
(Me-β-CD), and (2-Hydroxyethyl)-β-cyclodextrins (HE-β-CD) were purchased from
Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany (purity 99 %). D2O, DCl and
NaOD were also purchased from Sigma-Aldrich. Millipore water had conductivity
less than 0.05 μS. The pH values of the solutions were adjusted (± 0.2 units) by
adding adequate amounts of HCl or NaOH.
2.2 Absorption/Steady-State Fluorescence Spectroscopy.
The UV/Visible absorption spectra were measured on Cary-300 instrument
(Agilent) at room temperature, between 200 and 500 nm. Fluorescence spectra
measurements were scanned at room temperature, between 300 and 550 nm on a
Cary-Eclipse fluorimeter. Slit widths were 5 nm for both excitation and emission
monochromators, unless otherwise specified. pH values were recorded using a pH
meter (WTW 330i equipped with a WTW SenTix Mic glass electrode). Quartz
cuvettes (1.0 cm, 3.0 mL) were used in all spectroscopic measurements and were
obtained from Starna Cells Inc. (Atascadero, CA).
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2.3 pH-Titration Studies
The pH titration by UV–Visible absorption spectroscopic method was
accomplished by measuring the pH values of about 3 ml solutions contained in a
rectangular quartz cuvette with 1 cm optical path length, and the absorption spectra
were then recorded. To adjust pH, microliter volumes from 0.01 and 0.1M NaOH
solution were pipetted consecutively to achieve the indicated pH values. The pKa
value was finally determined from fitting the titration data at a selected wavelength
to sigmoidal formula derived from Henderson-Hasselbalch and Beer-Lambert laws.
The fitting algorithm was provided by SigmaPlot’s software (version 6.1; SPCC,
Inc., Chicago, Illinois, USA).
2.4 Steady-State Binding Titration Studies
In the titration experiment, the total concentrations of the W were kept
constant and that of the host was gradually increased. The pH of a certain volume of
H2O was first adjusted to either ~3 or ~9 in which a stock solution of W was
prepared to give a final concentration of ~25 μM. A calculated weight of β-CD
derivatives was added to the same solution of W to prepare the stock solution of the
complex (~ 3.5 mM). The solutions with the final concentration of β-CD were
prepared by gradually adding increment volumes of the complex’s stock solution to
2.4 ml of the free W directly in the quartz cuvettes. The absorption or fluorescence
spectra were measured for each solution. The signals at certain wavelength were
plotted as a function of host’s total concentrations. The intermolecular interaction
between β-CD and W may be quantified by the affinity constant referred to as the
association equilibrium (K):
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W + β-CD

𝐾=

W-β-CD

(1)

[𝑊−β−CD]

(2)

[𝑊][β−CD]

CW = [W] + [W-β-CD]

(3)

Cβ-CD = [β-CD] + [W-β-CD]

(4)

Where CW and Cβ-CD mean the total concentrations of W and β-CD, respectively. It
can be written that:
Y (Reading at certain λ) = constant 1 * [W] + constant 2 * [W-β-CD]

(5)

Using Eqs.(2)-(5), we obtain
Δ(constant)Cβ−CD

∆Y =

2
2
KCW −1−KCβ−CD +√(1−KCW +KCβ−CD ) +4KCW

+1

(6)

Where ΔY = optical changes at a given λ; Δ(constant)= the difference
between the molar absortivity of free and β-CD-complexed W in the case of
absorption titration, and K = binding constant. The binding constants (K) were then
evaluated by using the nonlinear formula of Eq. (6). Constant 2 was left as a floating
parameter in the analysis by Levenberg-Marquardt algorithm, which was provided by
SigmaPlot’s software.
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2.5 Time-Resolved Fluorescence Measurements
The emission decays of W in absence and presence of Me-β-CD at different
pH values were collected using LifeSpec II spectrometer that is based on TCSPC
method with excitation at 280 and 320 nm using two Edinburgh diode lasers with
repetition rate at 20 MHz, time resolution of 90 ps, and a red-sensitive high-speed
PMT detector (Hamamatsu, H5773-04). Emission decay were collected every 10 nm
over the entire emission spectra of W and W-β-CD complex in aqueous solution with
a dwell time of 50 s at each wavelength. The data were globally fitted to monoexponential and bi-exponential model functions depending on the tested sample, then
convoluted with instrument response function (IRF) of ~90 ps. The time-resolved
data were specifically analyzed using Edinburgh FAST software (Appendix) in
which decay-associated spectra (DAS) were constructed from the extracted intensitycontribution fraction (fi) calculated from the pre-exponential amplitudes (Bi), as
follows:
𝐼(𝑡) = ∑𝑖 𝐵𝑖 𝑒𝑥𝑝(−𝑡/𝜏𝑖 )
𝑓𝑖 = ∑

𝐵𝑖 𝜏𝑖

𝑗 𝐵𝑗 𝜏𝑗

(7)
(8)

𝜏: 𝑙𝑖𝑓𝑒𝑡𝑖𝑚𝑒 𝑓𝑜𝑟 𝑒𝑎𝑐ℎ 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛𝑖𝑐 𝑠𝑡𝑎𝑡𝑒 (𝑠𝑝𝑒𝑐𝑖𝑒𝑠)
Target analysis utilizing Glotaran software11 were performed to confirm the
kinetic expression for the population transfer of the two excited states that belong to
free and CD-complexed W. Results indicated two mono-exponentially in parallel,
which validates the meaning of DAS as described in text.
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Chapter 3: Results & Discussion
3.1 Preliminary Investigation
At the beginning of this work, the establishment of reversible and stimuliresponsiveness host-guest complexes to calcium ions in aqueous solutions was
pursued. The reversibility in drug retention and release can be achieved in response
to the added calcium ions to different host-guest complexes of warfarin with
cyclodextrins. While the drug causes blood bleeding, addition of calcium would then
replace the drug from the cavity of host, inducing blood clotting [39]. Our envisaged
results are inspired by recent reports [26], [37] on the possibility of reversibly tune
the binding affinity of the guest to different hosts utilizing host-induced pKa shifts
which is accompanied by modulation of fluorescence signal.
Collectively, our focus was on creating a balance between blood bleeding and
blood clotting that could be utilized in blood cells in the future while being
monitored online by emission signal. The inspiration specifically comes from the
ability of carbonyl-containing containers (see Ac-β-CD Figure 2) to tune the pKa
values of the embedded guests due to ion-dipole interaction.
Unfortunately, as shown in Figures 7-10 the pKa shift is less than 1 unit
between Warfarin and CDs. As a result, monitoring the stimuli responsiveness to
calcium becomes impractical under these conditions. Alternatively, we opted to
pursue the photochemistry of warfarin in water and inside CD with a similar aim
towards establishing stimuli-responsive, reversible system yet due to the ability of
host to induce molecular switching instead of pKa shifts.
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Figure 7: UV-Visible absorption spectra at different pH values of W in Me-β-CD
with Ca+2

+2

Figure 8: UV–Visible absorption spectra of W in aqueous solutions at different pH values
from 2-10 in water and inside Me-β-CD. The experimental fitting error for the indicated
pKa values and the corresponding spectra are shown in the insets
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3)

Figure 9: UV-Visible absorption spectra at different pH values of W in Ac-β-CD
with Ca+2

+2

Figure 10: UV–Visible absorption spectra of W in aqueous solutions at different pH
values from 2-10 in water and inside Ac-β-CD. The experimental fitting error for the
indicated pKa values and the corresponding spectra are shown in the insets
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3.2 Interactions of Warfarin with Cyclodextrins
Precedent reports on the interactions of W with several derivatives of CDs
[46], [49], [38], [50] have been considered in planning the experiments in this work.
Figure 11 shows new derivatives of β-CD were pursed, namely Acetyl-β-CD and 2Hydroxyl Ethyl-β-CD.

Figure 11: The structures of selected β-cyclodextrins macrocycles in the present
work that were not studied before with W
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3.2.1 Interactions of Warfarin with Ac-β-CD at pH 3
The rationale behinds our selection arises from the presence of additional
hydroxyl or carbonyl functional groups that could enhance interaction with W.
Unfortunately, Ac-β-CD cyclodextrin at pH 3 gave weak or no interaction with W, as
monitored by UV-Visible absorption measurements in Figure 12.

Figure 12 : UV–Visible absorption titration of W (25 μM) with Ac-β-CD at pH 3; the
inset shows the corresponding titration curve and the 1:1 binding fit (solid line) with
K = (5.5 ± 78) M‒1. The very large error in binding affinity reflects very weak
binding
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3.2.2 Interactions of Warfarin with Ac-β-CD at pH 9
In addition to that, even at pH 9 no isosbestic points was noticed as shown in
Figure 13. Consequently, Ac-β-CD gave no interaction with warfarin at high pH.
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Figure 13: UV–Visible absorption titration of W (25 μM) with Ac-β-CD at pH 9
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3.2.3 Interactions of Warfarin with Me-β-CD at pH 3
However, previously examined derivative Me-β-CD gave the highest binding
constants [49]. In Figure 14 at pH 3, only the open protonated form moderately
reacts with the host (K= 2,900 M-1) because isosbestic points were only seen at 305
nm. Vasquez et al. indicated that the absorption peak at 310 nm is attributed to the
warfarin form with an open side chain, and at 280 nm it is a cyclic hemiketal [46].
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Figure 14: UV–Visible absorption titration of W (25 μM) with Me-β-CD at pH 3; the
inset shows the corresponding titration curve and the 1:1 binding fit (solid line) with
K = (2.9 ± 0.3) × 103 M‒1
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3.2.4 Interactions of Warfarin with Me-β-CD at pH 9
However W¯ weakly binds CD at high pH (Figure 15) with binding constant
of 420 M-1 in agreement with previous reports [38], [46], [50].
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Figure 15: UV–Visible absorption titration of W (25 μM) with Me-β-CD at pH 9; the
inset shows the corresponding titration curve and the 1:1 binding fit (solid line) with
K = (4.2 ± 1.0) × 102 M‒1

Upon addition of Me-β-CD host molecules (up to 40 equivalents) to the
aqueous solutions of W at pH 3 and 9 (Figure 14,15), characteristic changes in the
UV–Visible absorption spectra were observed with the occurrence of several
isosbestic points (311 nm, 315 nm, and 320 nm) confirming the formation of a 1:1
binding stoichiometry [46].
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The corresponding binding constants between W and Me-β-CD at a given pH
were derived directly from the optical titration plot at a given wavelength using the
formula described in the experimental section.
Absorption spectra upon addition of β-CD to W in water at pH 7.4 (phosphate
buffer) were measured by Vullve et al., [46] suggesting that assumption of a 1:1 ratio
is valid for this particular molecular complex. W exists predominantly in its open
form when bound to β-CD [43], [44]. They attributed this observation to a steric
factor that forces W to remain in its open structure. Initially it was expected that
hydrophobic cavity of β-CD would stabilize the cyclic form by analogy to earlier
report in other hydrophobic media such as Cytochrome P450 2C9 (CYP2C9) [51] .
Addition of β-CD caused less than 10% change in the absorption at 310 nm. These
findings support the conclusion made by Vullve et al. [46] since only the longest
wavelength absorption maxima was affected upon addition of Me-β-CD, shifting
from 305 nm to 306 nm at pH 3.
3.3 Optical Measurements and Host-Induced pKa Shifts
A very recent experimental and theoretical investigations by Nowak et al. on
several hydroxycouamrin derivatives concluded that different location of hydroxyl
group should affect the value of pKa [52]. Motivated by this work, the changes of
absorption spectral profiles of W free and CD-complexes in aqueous solutions was
graphed as a function of pH values as shown in Figures 16-19.
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Figure 16: UV-Visible absorption spectra at different pH values of W in water. The
sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 nm (OPEN)
are shown in the insets
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Figure 17: UV-Visible absorption spectra at different pH values of W in HE-β-CD.
The sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 nm
(OPEN) are shown in the insets
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3)

Figure 18: UV-Visible absorption spectra at different pH values of W in Ac-β-CD
host. The sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320
nm (OPEN) are shown in the insets

3)

Figure 19: UV-Visible absorption spectra at different pH values of W in ME-β-CD.
The sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 nm
(OPEN) are shown in the insets
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Although Me-β-CD-induced pKa shifts corresponding to the deprotonation
processes of the hydroxyl group in coumarin ring (Figure 6) have been studied before
by Nowak et al. [49], our inspiration specifically comes from the expected
dependence of extracted pKa values on the selected wavelength in the corresponding
titration plots. Also, these experiments should serve fluorescence lifetime data at
different pH and confirm the strongest interactions with methylated CDs.
Figures 20-21 illustrated the pH titration plots for the cyclic and open forms.
Positive shifts in pKa were observed upon addition of all CD derivatives in aqueous
solution under similar conditions of ionic strength effects [53]. Regardless of the type
of isomer, Me-β-CD-assisted pKa shifts are always larger than those induced by Acβ-CD (ΔpKa ~ 0.9 vs. ~ 0.7 for open forms and ~ 0.6 vs. ~ 0.3 for cyclic forms). The
HE-β-CD induced the least pKa shifts (ΔpKa ~ 0.4 for open forms, and no shift
observed in case of cyclic forms).
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Figure 20: UV–Visible absorption spectra of W in aqueous solutions at different pH
values from 2-10 at λabs = 280 nm in water and inside HE-β-CD, Ac-β-CD, and Meβ-CD. The experimental fitting error for the indicated pKa values and the
corresponding spectra are shown in Figures 16-19
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Figure 21: UV–Visible absorption spectra of W in aqueous solutions at different pH
values from 2-10 λabs = 305 in water and inside HE-β-CD, Ac-β-CD, and Me-β-CD.
The experimental fitting error for the indicated pKa values and the corresponding
spectra are shown in Figure 16-19
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The host-induced pKa shifts reflect the changes in the binding affinities of drug to
β-CD derivatives in the ground states (see Me-β-CD as an example at pH 3 and 9 in
Figures 14-15), thus rationalized by the preferential interactions of host towards the
protonated form over the deprotonated one [54]. Nowak et al.,[49] attributed the
strongest pKa shifts in Me-β-CD to the presence of methyl group that may have
preferentially interacted with the CD cavity.
More important to the focus of this work is the observation that upon
inclusion in any of the three β-CD hosts, the increase in pKa of the open isomer was
more pronounced than that of cyclic one, supporting the selective interaction with
open form over the cyclic one.
In addition to that, open form of free W appears to be more acidic in ground
state (pKa 5.1 vs. 5.3) than the cylclic one, presumably due to extending electron
delocalization in the final charged product (W¯) in the former case [52].
3.4 Excitation, pH and Cyclodextrin Dependence of Warfarin Steady-State
Fluorescence
This work specifically aimed at investigating the dependence of fluorescence
of W on pH and excitation wavelength in the absence and presence of Me-β-CD, the
host which has sufficiently interacted with W by virtue of the above absorption
measurements. Fluorescence pH titration experiment was conducted as illustrated in
Figures 22-23. Different pKa values were extracted upon exciting W in water at 280
nm and 320 nm (pKa 6.1 vs. 5.7), which is again attributed to the deprotonation of the
hydroxyl proton (Figure 6) with the open form being more acidic.
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Figure 22: Fluorescence spectra of W (25 μM) at different pH values with excitation
at 320 nm ; the inset shows the experimental fit to a sigmoidal function (solid line),
which gives pKa = 5.70 ± 0.07. Slit widths were 5 nm for excitation and emission
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This could be ascribed to extended electron delocalization in the excited-state
structure of the formed deprotonated form in parallel to the behaviors of isomers in
the ground-state [53]. It must be noted that open and cyclic forms, despite having
similar emission peaks, gave different emission profile when excited at 280 nm and
320 nm as illustrated in Figure 24, confirming the persistence of intramolecular

Fluorescence Intensity

proton transfer from the open form to cyclic tautomer (Figure 6) in the excited state.
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Figure 24: Fluorescence spectra of W (25 µM) at pH 2.5 and 10 with λex = 320 nm
and λex = 280 nm as labeled by a distinct color. While no change in peak position,
spectra of neutral W excited at 280 nm (dark yellow) and 320 nm (dark green) are
different
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As far as the effects of CDs on emission of W, contrarily to the observed
three-fold fluorescence enhancement upon inclusion of W¯ form at pH 9 (Figure 25;
excitation at 320 nm) with binding affinity of 266 M-1 in agreement previous reports
[38], [46], [50], the protonated (open or cyclic) forms at pH 3 showed very weak
enhancement in fluorescence upon addition of 10 equivalents of host as illustrated in
Figures 26-27. These contradictable results warrant further investigations using timeresolved fluorescence spectroscopy.
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Figure 25: Fluorescence titration of W (25 μM) with Me-β-CD at pH 9 with
excitation at 320 nm the inset shows the corresponding titration curve and the 1:1
binding fit (solid line) with K = (2.66 ± 0.06) × 102 M‒1
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Figure 26: Fluorescence spectra of W (25 µM) at pH 3 upon the addition of Me-βCD up to 250 µM (10 equiv.) with λex = 320 nm, no significant changes in spectra
were observed
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Figure 27: Fluorescence spectra of W (25 µM) at pH 3 upon the addition of Me-βCD up to 250 µM (10 equiv.) with λex = 280 nm, no significant changes in spectra
were observed
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3.5 Fluorescence Lifetime Measurements/Decay-Associated Spectra (DAS)
Time-resolved fluorescence measurements of W at pH 3 and 9 in absence and
presence of Me-β-CD was opted to rationalize the no enhancement in fluorescence of
protonated W upon inclusion compared to those results observed at pH 9. Also
sought to separate the sequestering effects of CD on each protonated isomer (open
vs. cyclic), by monitoring the change in excited-state lifetime when selectively
exciting W at 320 nm and 280 nm, respectively.
Previously, the two forms were simultaneously excited at 300 nm [45].
Emission decays collected every 10 nm across the entire emission spectra of free W
at pH 3 upon excitation at 320 nm and 280 were globally fitted to monoexponential
decays as shown in Figures 32-33 (Appendix) and tabulated in Table 2.
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Table 2: Spectroscopic and photophysical data of W at 25 µM in absence and in
presence of Me-β-CD (1.0 mM). The DAS maximum for each lifetime is given in
bracket
τ1 / ns
(λem / nm)

τ2 / ns
(λem / nm)

Drug Forms

λabs / nm

λex / nm

λem / nm

W, OPEN
(pH 3)

305

320

358

W, CYCLIC
(pH 3)

282

280

358

W¯
(pH 9)

308

320

390

W-Me-β-CD,
OPEN
(pH 3)

306

320a

358

< 0.1
(358)

2.0±0.4b
(375)

W¯-Me-β-CD
(pH 9)

309

320

390

< 0.2
(390)

1.22±0.02b
(390)

< 0.1
< 0.2
< 0.2

a

Upon excitation at 280 nm, no change in excited-state lifetime was observed upon inclusion
at pH 3. b Values are presented as mean ± standard deviation. The estimated experimental
error was 20% and 1.6% for the complex lifetimes at pH 3 and 9, respectively.

The excited-state lifetimes appear within our instrument resolution of 90 ps in
agreement with others [45]. However, when Me-β-CD complex were excited at pH 3
both mono-exponential and biexponential decays were observed as shown in Figures
34-35 (Appendix).
Although addition of CD at pH 3 did not affect the position of peaks (390
nm), excited-state lifetime increased but only when the complex was excited at 320
nm, and not 280 nm (Figure 28, 34 and 35), supporting that Me-β-CD host favors the
open tautomer form. Even though emission decays of drugs were collected in Figures
28-29 upon addition of 40 equivalents of host (as limited by its solubility in water of
about 15 mM), complete formation of complex has not been achieved due to
relatively weak binding constant.

Photon Counts / a.u.
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Figure 28:Emission decays collected at 370 nm for W at 25 µM in absence and in
presence of Me-β-CD (1.0 mM) upon exciting at 320 nm. IRF is the instrument response
function of ~ 90 ps
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Figure 29: Emission decays collected at 370 nm for W at 25 µM in absence and in
presence of Me-β-CD (1.0 mM) upon exciting at 280 nm. No change in fluorescence
lifetime upon excitation at 280 nm. IRF is the instrument response function of ~ 90
ps
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Accordingly, the corresponding DAS spectra in Figures 30-31 (see
experimental section) are thus best interpreted by assuming contribution from both
free and CD-complexed drug. The emission of free drug at pH 3 dominates the
emission spectrum with emission band centered at 358 nm (Figure 30). The
corresponding complex at this pH has an emission peak at ~ 375 nm with a longer
excited-state lifetime ~ 2.0 ns, yet a much lower emission quantum yield (0.006 vs.

Fluorescence Intensity / a.u.

0.0005 in Table 3).
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Figure..30: Decay-associated spectra (DAS) of two-component mixture of
flurophores for W-Me-β-CD host-guest complex (25 μM for W and 1 mM for WMe-β-CD) at pH 3 upon exciting at 320 nm at room temperature. The corresponding
steady-state spectra of each solution are also shown for comparison (see
experimental section)
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Figure..31: Decay-associated spectra (DAS) of two-component mixture of
flurophores for W-Me-β-CD host-guest complex (25 μM for W and 1 mM for WMe-β-CD) at pH 10 and upon exciting at 320 nm at room temperature. The
corresponding steady-state spectra of each solution are also shown for comparison
(see experimental section)

Separation of the two lifetimes by DAS method enables us to calculate
radiative (kr) and non-radiative rate constants (knr) alongside emission quantum yield
(ФF) upon complexation of W to Me-β-CD, as illustrated in Table 3.
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Table 3: Fluorescence quantum yield ФF, Radiative rate constant kr, and Nonradiative rate constant knr

Drug Forms

λex / nm

ФF (× 10-3)a

kr (× 107 s-1)b

knr (× 109 s-1)b

τ / ns
(Mean)

W
OPEN

320

6 ± 0.01

>6

> 10

< 0.1

W¯

320

12 ± 0.01

> 12

> 10

< 0.1

Me-β-CD
OPEN

320

0.5 ± 0.01

0.02

0.50

2.0

W¯-Me-β-CD

320

24 ± 0.01

2.0

0.81

1.22

a

Measured using warfarin (W) in phosphate-buffered saline (PBS, pH ~7.4, 10 mM sodium
phosphate) as the standard (ФF = 0.012) [46], and calculated using the known equation [55] :
2
𝐼𝑢𝑛𝑘
𝐴
𝑛
) ( 𝑠𝑡𝑑 ) ( 𝑢𝑛𝑘 ) ,
𝐴𝑢𝑛𝑘
𝐼𝑠𝑡𝑑
𝑛𝑠𝑡𝑑

∅𝑢𝑛𝑘 = ∅𝑠𝑡𝑑 (

where n is the refractive indices for the standard (std)

and experimental (unk) solvents, I is the fluorescence integral of the emission between 300
and 550 nm, and A is the absorbance at the excitation wavelength. b Calculated using the
kr
1
1−∅
∅
known equations: ∅ =
,τ=
, k nr =
, and k r = .
kr +knr

kr +knr

τ

τ

The variations of kr values in the absence and presence of CD are difficult to
explain because of the unreliable measurement of lifetimes in water. However, the
red shifts of emission peaks of W upon complexation to Me-β-CD hosts at pH 3
despite their non-polar hydrophobic and rigid cavity along with concomitant
significant decrease of the kr values by ~2 orders of magnitude, from kr = ~6 ×107 to
2 × 105 s-1, means that the enhancement in excited-state lifetimes is best described by
a radiative-rate law [55].
This argument is supported by the boarder UV-visible spectrum of W when
compared to that spectrum in water upon inclusion to CD, as shown in Figure 14 and
in light of Strickler-Berg equation [55].

Karlsson et al. [45] pointed out the

possibility of attributing the longer lifetime of W observed in ethanol (0.45 ns, λex =
295 nm) to the formation of solute-solvent hydrogen-bonded complexes.
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Dondon et al. [56] also posited that for other 4-hydroxycoumarin derivatives
similar hydrogen-bonded complexes could have formed between the coumarin
lactone group and the CD secondary hydroxyl groups. It transpires that there is a
plausible explanation to the fluorescence behaviors of protonated W-CD systems that
similar hydrogen-bonded complexes have formed between CD secondary hydroxyl
group and the carbonyl group of open form, which the cyclic form lacks.
It is worth to mention that the low binding affinity of our W-CD system in
the present study limits its potential use for biomedical applications as a large
fraction of free guest will always persist at any concentration of the added host.
However, understanding the factors that enhance the binding constants of W
with CDs such as the formation of hydrogen bonded complexes [45], [56] and the
presence of methyl groups [49] alongside the investigation of pH effects on the
complex stability should preclude further studies in the future on W-CD systems for
the establishment of pH-driven stimuli-responsive systems.
Emission decays collected at pH 9 Figure 36 and 37 (Appendix) gave DAS
spectra (Figure 31) that demonstrated opposite effects induced by CD addition. In
agreement with previous reports [46], [51], [57], the complex at pH 9 excited at 320
nm has a higher emission yields than that of free drug with excited-state lifetime of
1.22 ns and no change in peak position at ~ 390 nm (Table 3). Vasquez et al.,
suggested encapsulation of deprtonated W forms considerably suppresses the
vibronic modes that provide pathways for non-radiative transitions between the
excited and ground states of W, causing a decrease in the rates of the non-radiative
decay processes.
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Indeed, calculation supports these findings and the operation of energy-gap
law in which the excited state S1 is more polar than the ground state S0.
Consequently, S1 state will be much more destabilized in a nonpolar medium than
the S0 state. Such an increase in energy gap results in a decrease in knr [58].
While non-radiate rate constants in Table 3 decreases ~ 12 times upon
inclusion in the hydrophobic interior of Me-β-CD, radiative rate constants decreases
only ~ 6 times. The increase in lifetimes and associated decrease in knr of other 4hydroxycoumarin derivatives [56] from below 0.5 ns to 1.1–1.3 ns (depending on the
derivative) was also observed upon sequestration of dyes into β-CD macromolecules.
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Chapter 4: Conclusion
In this work, time-resolved fluorescence spectra measured using picoseconds
laser diode at 280 nm and 320 nm with selective exciting of isomers of W were
conducted utilizing both global and target analysis to give more specific information
about nature and dynamics of excited-states of warfarin in water and inside
cyclodextrins. An increase in excited-sate lifetime of warfarin was observed upon its
interaction with Me-β-CD with selective interactions towards the open form. The
increase in lifetime of open form was explained by radiative rate law, while that of
deprotonated form by energy-gap law. Lower acidity of the open form have been
demonstrated.
Fluorescence properties of W inside cyclodextrins in aqueous solutions have
attracted attentions in several occasions due to their implications in bioanalytical
quantification of W in commercial pesticides [50], [59]–[61] or biological liquids
[62] and in utilizing W as fluorescent probes or site marker to study drug-protein
interactions [63], [64].
In addition to fluorescence properties better understanding of the interactions
of W with cyclodextrin in ground-state should lead to better control on modulating
its pKa values in solution [38], [49], with implications in analytical separation of drug
by electrophoresis [53] liquid chromatography [65], [66], as well as its formulations
[67] or clinical studies [68].
In summary, these results give the structures present in cyclodextrin
environment in ground-state and explain their kinetic behaviors in excited-state using
quantitative time-resolved fluorescence tools, collectively leading to better
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understanding on the role of cyclodextrin on manipulating the function of this
anticoagulant drug in ground and excited states.

4.1 Recommendations
The following recommendations are suggested as possible ways to extend
this study:
1-Study the host-guest interactions of W with different macromolecules such
as cucurbit[n]uril and other different cyclodextrins.
2-Warfarin was selected because it is commercially used as drug that favors
blood bleeding, while finding a stimuli (chemical competitor) that tune the form
(open and cyclic) could control blood clotting/bleeding balance in the future.
3- Study the photochemistry of other drugs and the encapsulation of these
drugs with different macromolecules.
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Counts

Appendix

Figure 32: Collected emission decays measured over the emission spectrum of W at
pH 3, excited at 320 nm from 330 to 490 nm every 10 nm with a dwell time of 50 s
at each wavelength. Data at each wavelength were fitted to a mono-exponential
model convoluted with IRF ~ 90 ps (as shown in the residuals)
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Figure 33: Collected emission decays measured over the emission spectrum of W at
pH 3, excited at 280 nm from 310 to 510 nm every 20 nm with a dwell time of 50 s
at each wavelength. Data at each wavelength were fitted to a mono-exponential
model convoluted with IRF ~90 ps (as shown in the residuals)
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Figure 34: Collected emission decays measured over the emission spectrum of WMe-β-CD at pH 3, excited at 320 nm (Figure30) from 330 to 480 nm every 10 nm
with a dwell time of 50 s at each wavelength. Data at each wavelength were fitted to
a bi-exponential model convoluted with IRF ~ 90 ps (as shown in the residuals)
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Figure 35: Collected emission decays measured over the emission spectrum of WMe-β-CD at pH 3, excited at 280 nm from 310 to 510 nm every 20 nm with a dwell
time of 50 s at each wavelength. Data at each wavelength were fitted to a monoexponential model convoluted with IRF ~ 90 ps (as shown in the residuals)
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Figure 36: Collected emission decays measured over the emission spectrum of W at
pH 9, excited at 320 nm from 330 to 550 nm every 10 nm with a dwell time of 50 s
at each wavelength Data at each wavelength were fitted to a mono-exponential
model convoluted with IRF ~ 90 ps (as shown in the residuals)

Counts

56

Figure 37: Collected emission decays measured over the emission spectrum of WMe-β-CD at pH 9, excited at 320 nm (Figure 31) from 330 to 550 nm every 5 nm
with a dwell time of 50 s at each wavelength. Data at each wavelength were fitted to
a bi-exponential model convoluted with IRF~ 90 ps (as shown in the residuals)
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